The basics of preclinical drug development for neurodegenerative disease indications

Overview of attention for article published in BMC Neurology, June 2009

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

news: 3 news outlets
policy: 2 policy sources

twitter: 4 X users
patent: 2 patents

Citations

dimensions_citation: 90 Dimensions

Readers on

mendeley: 615 Mendeley
citeulike: 2 CiteULike

Summary News Policy documents X Patents Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

A study assessing scientific, engineering, legal and economic considerations of flexible EU manufacturing and innovation of medical countermeasures for serious cross-border threats to health

Cited by The Publications Office of the European Union on 16 Jun 2023

The Publications Office of the European Union (Publications Office), based in Luxembourg, is an interinstitutional office whose task is to publish the publications of the institutions of the European Union.

Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development: Workshop Summary

Cited by National Academies Press on 01 Jan 2012

The US National Academies Press (NAP) was created by the National Academy of Sciences to publish the reports of the National Academies of Sciences, Engineering and Medicine, operating under a charter granted by the Congress of the United States. The NAP publishes on a wide range of topics in science, engineering, and medicine, providing authoritative information on important matters in science and health policy.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.